Summary A medical record-based study of leukaemia and non-Hodgkin's lymphoma diagnosed before the age of 30 years was carried out at three hospitals in the south of England. Findings for 177 cases and 354 age-and sex-matched controls are presented here. For documented viral infection in pregnancy, the odds ratio (OR) was 6.0 [95% confidence interval (Cl) 1.2-29.7] for leukaemia and infinity (95% Cl 1.2-) for non-Hodgkin's lymphoma. Mothers of leukaemic cases were more likely to be anaemic, the OR for a pregnancy haemoglobin below 10 g being 3.8 (95% Cl 1.3-11.1). An association with birthweight was found for acute myeloid leukaemia, the OR for birthweights > 3500 g being 6.2 (95% Cl 1.3-29.8). Further, the preceding siblings of those diagnosed with any form of leukaemia were also more likely to weigh > 3500 g at birth (OR 2.2; 95% Cl 1.1-4.4). Overall, leukaemic cases appeared to be comparatively robust at birth with respect to other indicators of well-being, the ORs for jaundice, phototherapy, admission to special care nursery and neonatal intensive care all being less than 1.0. Further, no relation between childhood leukaemia and neonatal administration of intramuscular vitamin K was noted (OR 0.6, 95% Cl 0.3-1.4; for acute lymphoblastic leukaemia diagnosed between the ages of 1 and 6 years).
Epidemiological evidence that in utero exposures could be an important determinant of childhood malignancy was first provided by the Oxford Survey of Childhood Cancers over 40 years ago, when an association between abdominal radiography of mothers during pregnancy was related to the subsequent development of leukaemia and other cancers in their children (Stewart et al, 1956 (Stewart et al, , 1958 . While this association was initially greeted with some scepticism, it is now generally accepted that the fetus and the young child may be more susceptible to the effects of ionizing radiation than the adult. Modem concern revolves mainly around the importance of the magnitude of the dose and the gestational age at the time of exposure (Doll, 1973; Bithell and Stiller, 1988; Gilman et al, 1988;  Mole, 1990; Wakeford, 1995) .
Interest in the potential carcinogenic effects of in utero exposures was rekindled in 1971 when Herbst and colleagues reported a striking association between the development of adenocarcinoma of the vagina in young women and their mothers' use of diethylstilboestrol in pregnancy. Since then, an ever-lengthening list of prenatal and neonatal factors have been suggested as possible risk factors for cancer in general, and for leukaemia in particular, although much of the evidence for such associations is sparse or contradictory. Recently, however, although no candidate exposures were identified, Ford and colleagues (1993) provided molecular evidence that rearrangements of the gene at 11 q23 seen in the majority of infant leukaemias could originate in utero; and in a further report they suggested that T-lineage malignancies in older children could also be initiated in utero (Ford et al, 1997) .
We describe here the main findings from a medical record-based case-control study of leukaemia and non-Hodgkin's lymphoma diagnosed in individuals before their 30th birthday who were born at one of three hospitals in the South of England. This study was specifically designed to examine the relation between disease and a range of prenatal and neonatal factors and exposures. Preliminary results concerning the association between leukaemia diagnosed before the age of 15 years and the administration of intramuscular vitamin K have already been published (Ansell et al, 1996) .
DATA AND METHODS
Cases comprise individuals diagnosed with leukaemia or nonHodgkin's lymphoma in the UK between the ages of 3 months and 29 years whose mother's obstetric notes were stored at one of three hospitals: the John Radcliffe (Oxford), the Rosie Maternity (Cambridge) or the Royal Berkshire (Reading) . Good-quality historical maternity records were available in a readily accessible form in all three hospitals, the obstetric notes of women delivering within the catchment area of the study hospitals (or their predecessors) having been routinely kept in paper or microfilm form in Cambridge, Oxford and Reading from 1956 , 1938 and 1969 Cases were identified from two sources: children (0-14 years) diagnosed between 1962 and 1992 from the Childhood Cancer Research Group (Stiller et al, 1995) and young adults (15-29 years) diagnosed between 1972 and 1987 from routine cancer registrations compiled by the Office of National Statistics (ONS). In both the information held by us was correct and also to provide additional details about any differences between the individual's surname at cancer registration and their mother's surname at the time of their birth. For each case whose mother's obstetric notes were located, two controls (matched on hospital catchment area of birth, sex and year and month of birth) were selected from delivery registers held at the study hospitals. Controls were chosen by generating two random times (day/hour/minute) within the month of birth of the case and by searching through all available delivery registers to identify the two babies who were born closest to those times. As for cases, information recorded in the delivery register was then used to locate obstetric notes. When the obstetric notes of a control identified from the delivery registers could not be found, a further day/time was generated and a replacement control was selected.
Cases and controls who, on inspection of the notes, were found to be members of a multiple pregnancy or who had died before discharge from hospital were considered ineligible. Babies with identifiable chromosomal anomalies (e.g. Down's syndrome) or other severe malformations (e.g. spina bifida) were excluded from the pool of potential controls, and cases with such conditions were subsequently excluded from the analyses presented here.
Information on our success in finding delivery records, obstetric notes of cases and obstetric notes of controls identified from the delivery registers is given in Delivery details, maternal obstetric notes and, when the child was admitted to a special care nursery, neonatal notes and information contained within the nursing cardex were abstracted by experienced research nurses (three midwives and one paediatric nurse) using structured forms and coding procedures specially designed by us to be applicable in a variety of settings. As well as information recorded in medical notes, historical details about each hospital's vitamin K policy were also sought from current hospital staff. Data were entered onto computer, checked and subsequently analysed using standard statistical techniques (Breslow and Day, 1980) and computer software (SPSS, 1989; Epicure, 1993; Stata, 1995) . Relative risks were estimated as matched odds ratios using conditional logistic regression. Two-sided P-values and 95% confidence intervals (95% CI) are presented throughout. Non-cephalic presentation 
RESULTS
The characteristics of cases included in the analyses are shown by diagnosis in The majority of the results that follow relate to all age groups combined. All analyses were, however, repeated for finer age groupings (0-4, 5-9, 10-14 and 2 15 years) and, when informative, age-specific results are also presented. There are no statistically significant differences between cases and their corresponding controls with respect to the maternal variables listed in Table 3 . For the leukaemias, however, the marginal differences between cases and controls with respect to maternal age and numbers of previous pregnancies may be worth noting as both are in directions that have been reported before -leukaemic case mothers being, on average, slightly older and having fewer past pregnancies. Nonetheless, there is little support for the hypothesis that leukaemia is more common among individuals who have no older brothers or sisters: the odds ratios for first live-born child being 1.0 (95% confidence interval 0.6-1.5), 0.9 (95% CI 0.6-1.5) aEstimated using informative matched sets. bper 100 ml.
and 0.4 (95% CI 0.1-2.0) for all leukaemias, acute lymphoblastic leukaemia and acute myeloid leukaemia respectively. There is, however, limited support for the proposition that the mothers of leukaemic case children were more likely to have experienced fertility problems, as can be seen more clearly in Table 4 . At the time of their first antenatal visit for the index pregnancy, 13 case mothers and 13 control mothers reported undergoing fertility investigations of some kind (odds ratio 2. 1; 95% CI 0.9-4.6). Of the five cases and five controls treated specifically for the index pregnancy (OR 2.0; 95% CI 0.6-6.9), four cases and three controls had hormonal therapy (OR 2.7; 95% CI 0.6-11.9). Information about the delivery and treatment of the neonates is given in Table 6 in which the adjusted odds ratios for non-cephalic presentation, jaundice, low birthweight and admission to a special care nursery are given. With the exception of low birthweight, adjustment of the crude odds ratio for potential confounding factors moved the risks closer to unity. Indeed, as might be anticipated, the adjusted odds ratio for admission to a special care nursery reverted to 1.0 (95% CI 0.2-5.4) when presentation, jaundice and low birthweight were taken into account. In contrast to the 34 babies who developed non-Hodgkin's lymphoma later in life, the 143 babies who developed leukaemia in childhood or early adulthood did not appear to be particularly disadvantaged at birth (Table 5 ). This lack of association is especially important for drugs given in labour, neonatal jaundice, phototherapy and neonatal administration of intramuscular vitamin K, all of which have been suggested as risk factors for In the acute myeloid group, the average birthweights were 3615 g (standard error 107 g) and 3215 g (s.e. 84 g) for cases and controls respectively. Further information about the relation between birthweight and leukaemia is presented in Table 7 , which shows the age-specific data and also a comparison between index babies (cases and controls) and, for those whose mothers had a previous birth, their immediately preceding siblings. Overall, for age, the odds ratios tend to increase as age increases, but the trend is not statistically significant (P = 0.06, for all leukaemias combined). The findings for birthweights of preceding siblings are perhaps more intriguing: at 7.6 (95% CI 0.9-63.9), the odds ratio for birthweights of 3500 g or more among preceding siblings in the acute myeloid group are of borderline statistical significance. In addition, there is some suggestion that the preceding siblings of children diagnosed with acute lymphoblastic leukaemia were heavier than the preceding siblings of their corresponding controls (OR 1.9; 95% CI 0.9-4.2), contributing to the fact that the odds ratio for all leukaemias combined was 2.2 (95% CI 1.1-4.4).
Information about maternal illnesses, radiography and drugs prescribed during pregnancy are presented in Table 8 . Two notable case-control differences were found for maternal illnesses during pregnancy; the first being for viral infection and the second for anaemia. In the leukaemia group, information about a viral infection during pregnancy was recorded in the notes of six case mothers and two control mothers (OR 6.0; 95% CI 1.2-29.7) and, for non-Hodgkin's lymphoma, in the notes of two case mothers and no control mothers, yielding an odds ratio of infinity (95% CI 1.2-c). Table 9 . The mothers of both control children were diagnosed with influenza, as were three of the mothers whose children went on to develop acute lymphoblastic leukaemia. Of the remaining five cases, two of their mothers had vulval warts, one had herpes simplex, one had rubella and one had chicken pox. All eight case children were under 8 years old when their disease was diagnosed, and the gestational ages at in utero infection ranged from 6 to 34 weeks. Furthermore, although the numbers are small, it may be worth noting the sexes of the affected children: only two were female (both of whose mothers had genital warts), a male-female sex ratio of 3.0.
Seventeen mothers of leukaemic children and 15 mothers of control children (Table 8) were diagnosed with anaemia during the index pregnancy (OR 2.4; 95% CI 1.2-5.0). Of those so diagnosed, 11 cases and six controls had at least one haemoglobin below 10 g (OR 3.8; 95% CI 1.3-11.1). No association with nonHodgkin's lymphoma and anaemia is evident. Further information about the 17 mothers and children in the leukaemic group (11 cases and six controls) with haemaglobins below 10 g is presented in Table 10 . Details about therapy for anaemia were recorded in the notes of 9 (82%) of the 11 cases and all five of the controls: three case mothers and one control mother were transfused, and two of the transfused case mothers had a bone marrow biopsy. Despite their mothers' anaemia, the leukaemic case babies appeared remarkably healthy, with birthweights ranging from 3290 g to 4860 g (mean 3854 g). Two notable features of the leukaemic cases are the female preponderance (male-female sex ratio 0.8) and their comparatively late age at diagnosis: the odds ratios increase from 1.3 (95% CI 0.2-8.0, based on two cases and three controls) under 5 years of age to 3.9 (95% CI 0.7-20.9, based on five cases and three controls) at 5-14 years and reach infinity (based on four cases and no controls) at 15 years of age or more (test for trend with age; Z = 3.6, P < 0.01).
No other statistically significant associations were found for exposures during pregnancy, although the findings for anticonvulsant usage and pelvimetry are similar to those that have been reported before (Table 8 ). In addition to the data given in Table 8 , information about a range of other drugs and vitamins were recorded in the hospital notes; all were examined and no statistically significant associations were found. The findings are not presented here because the numbers of subjects were often small, and there was considerable overlap between the exposures -some women having several drugs listed while the majority had none at all. In view of the findings for anaemia, however, it is notable that no case-control differences with respect to the prescription of iron and/or folic acid were apparent.
DISCUSSION
The investigation described here was specifically designed to examine the relation between prenatal and neonatal factors and the subsequent development of haematological malignancies in children and young adults, its success depending on the ability to link routinely collected cancer registration data with good quality obstetric information. While the results presented here could have been affected by chance because of small numbers, we believe that they are unlikely to have been biased; information about exposure was abstracted from records compiled before diagnosis, and the 'find' rate for obstetric records was high at 85%. Inspection of the delivery records of case and control babies whose mother's obstetric notes could not be traced, revealed nothing unusual (data not shown), making it unlikely that the obstetric records of subjects whose notes we could not find differed in important respects from those we could. Further, although the four research nurses (three midwives and one paediatric nurse) who traced and abstracted the medical notes were not 'blind' to case-control status, great care was taken to ensure that such knowledge did not result in biased data collection; the tightly structured abstraction forms and coding procedures were designed and tested before the study began, and cross-checks in the form of duplicate abstractions and coding were used for initial training and periodically throughout for quality control.
The study does, however, have certain weaknesses, although it is not clear how our findings would have been influenced by them. Some individuals diagnosed with cancer who were born within the catchment areas of the study hospitals (or their predecessors) in the years for which obstetric data were being obtained will have been missed, either because their NHS number was not added to the cancer registration databases or because their cancer was not registered in the national scheme. Estimating this shortfall with any degree of accuracy is not possible as reliable cancer registration data are not available for the earlier years and annual tallies of births were not kept at the study hospitals. Further, while we know that the controls were alive and had no serious anomalies diagnosed before discharge and that they did not have a cancer registration with an NHS number attached, we cannot be certain that they were alive and cancer free when their corresponding case was diagnosed.
Characteristics of the baby and neonatal exposures
There is strong evidence that certain genetic conditions predispose towards malignancy in later life, male sex and Down's syndrome being well-recognized risk factors for childhood leukaemia for example Doll (1989) . In the present study, cases and controls were matched on sex, and babies with chromosomal anomalies were excluded as these variables would have acted as strong confounders in many of the analyses.
A number of investigators have reported that heavy birthweight is a risk factor for childhood leukaemia (MacMahon and Newill, 1962; Fasal et al, 1971; Wertelecki and Mantel, 1973; Shu et al, 1988; Kaye et al, 1991; Cnattingius et al, 1995; Ross et al, 1996) , although others have found no such relation (McKinney et al, 1987; Golding et al, 1990; Zack et al, 1991) . Most studies to date have concentrated either on infants or on children diagnosed before the age of 15 years, some concluding that the association between birthweight and leukaemia is strongest for younger ages, some that it is more pronounced for acute lymphoblastic leukaemia and some that the birthweight effect predominates in one sex or the other (for review see Ross et al, 1996) .
On balance, our findings support the view that factors associated with fetal growth may also be associated with the subsequent development of leukaemia, particularly of the acute myeloid type in which a sixfold increase in risk was found for babies weighing more than 3500 g. However, no statistically significant trends with age at diagnosis were detected for all leukaemias combined or for acute lymphoblastic leukaemia alone, and examination of our data for men and women separately did not reveal any systematic differences (data not shown). Further, the observation that older siblings of leukaemic children were also comparatively heavy at birth cautions against ascribing a direct causal link between birthweight and leukaemia, the inference being that other factor(s) could be responsible for both phenomena.
As well as having relatively high birthweights, the leukaemic cases appeared comparatively robust at birth with respect to other indicators of well-being, the odds ratios for jaundice, phototherapy, admission to special care nursery and neonatal intensive care all being less than 1.0. Although the numbers are small, it should be noted that our findings for phototherapy agree with those of Cnattigius and colleagues (1995) , offering little support for the hypothesis that neonatal exposure to strong illumination is a material cause of acute lymphoblastic leukaemia (BenSasson and Davis, 1992) .
The lack of an association between leukaemia and administration of intramuscular vitamin K to the neonate also deserves particular attention as, after the report of Golding and colleagues in 1992, this issue has been the subject of considerable debate (Draper and Stiller, 1992; Ekelund et al, 1993; Olsen et al, 1994; Ansell et al, 1996; von Kreis et al, 1996; Zipursky et al, 1996) . The retrospective assessment of whether a baby received vitamin K and by what route is not straightforward (Ansell et al, 1996) and, because of this, we presented our results in two ways, firstly by what was recorded in the notes and secondly by what could be imputed about hospital policy. With either method, our findings do not support the suggestion of an association between intramuscular vitamin K and leukaemia. In a recent report von Kreis and colleagues (1996) presented data on acute lymphoblastic leukaemia for children aged between the ages of one and six years calculating an adjusted odds ratio for administration of intramuscular vitamin K of 1.2 (95% CI 0.7-2.2). For comparative purposes, our data for the same disease group and age range produced an odds ratio of 0.6 (95% CI 0.3-1.4) based on hospital notes and 0.6 (95% CI 0.2-1.7) based on hospital policy; adjustment for potential confounders, such as admission to a special care nursery and mode of delivery, had no material effect.
Relatively little obstetric data has been published for nonHodgkin's lymphoma, and the present report only contains information on 34 cases. McKinney and colleagues (1987) studied 31 children with non-Hodgkin's lymphoma and found that they were significantly lighter at birth than their corresponding controls. As we also found that at birth the non-Hodgkin's lymphoma cases appeared generally disadvantaged (although not significantly so) by comparison with their own controls, and by comparison with the leukaemic cases, further research on the relation between prenatal and neonatal factors and non-Hodgkin's lymphoma may be warranted.
In utero exposures
The suggestion that in utero exposure to viral infection, particularly influenza and varicella, may predispose towards leukaemia is not new, although the evidence is inconsistent (Stewart et al, 1958; Adelstein and Donovan, 1972; Fedrick and Alberman, 1972; Leck and Steward, 1972; Doll, 1973; Hakulinen et al, 1973; Fine et al, 1985; McKinney et al, 1987; Gilman et al, 1989; Anon, 1990; Ross et al, 1994) . Taken at face value, the approximately sixfold increased risk found here supports the hypothesis that prenatal viral infection may be related to the subsequent development of not only childhood leukaemia (six cases and two controls) but also of childhood non-Hodgkin's lymphoma (two cases and no controls). However, as with birthweight, this finding should not necessarily be taken to imply a direct causal relation as the documented exposures relate to the manifestation of clinically diagnosed maternal viral disease and not to documented fetal exposure to a viral infection. Unfortunately, information about whether the two cases of vulval warts and the one case of herpes simplex were incident cases (diagnosed for the first time in the index pregnancy) or were severe eruptions of a pre-existing condition were not recorded in the notes.
As far as we are aware, the possibility that maternal anaemia in pregnancy may be related to leukaemia has not been suggested before, although data contained within a report on the Oxford Survey of Childhood Cancers show a positive association between anaemia and all cancers combined (Gilman et al, 1989) . A striking feature of our data is the difference between the ages and sexes of the leukaemias associated with anaemia in pregnancy and those associated with viral infection: the former being predominantly older female cases and the latter younger male cases. As with the findings for birthweight and viral infection, however, the meaning of the almost fourfold increase in risk associated with a maternal haemoglobin below 10 g is unclear. Although it is possible that lack of a nutrient while in utero, such as iron or folate, could predispose towards leukaemia, it is also possible that the mother's anaemia and the offspring's leukaemia could, in fact, share a common cause.
Apart from viral infection and anaemia, there was little support within our data for associations between leukaemia and maternal use of anticonvulsants or antibiotics during pregnancy or with drugs given to the mother in labour, the odds ratios for anaesthetics, entonox and pethidine all being close to unity (Doll, 1973; KinnierWilson et al, 1981; McKinney et al, 1985; Robison et al, 1988; Gilman et al, 1989; Golding et al, 1990; Cnattingius et al, 1995) .
Maternal characteristics and birth order
A number of investigators have suggested that certain characteristics of the mother could predispose towards leukaemia in her offspring. This is a complex area as disentangling relationships between a mother's prior reproductive history, her age and the birth order of the affected child is not straightforward.
Although some researchers have found an association with advanced maternal age (Stewart et al, 1958; MacMahon and Newill, 1962; Stark and Mantel, 1966; Shaw et al, 1984; Kaye et al, 1991) , others have not (Fasal et al, 1971; Salonen, 1976; van Steensel-Moll et al, 1985; McKinney et al, 1987; Shu et al, 1988; Golding et al, 1990 Golding et al, , 1992 Kaye et al, 1991; Zack et al, 1991; Cnattingius et al, 1995) . Similarly, while it has been suggested that being the first-born child may be a risk factor for leukaemia (MacMahon and Newill, 1962; Stark and Mantel, 1966; van Steensel-Moll et al, 1986; MacMahon, 1992) , many studies have failed to confirm this association (Fasal et al, 1971; Salonen, 1976; Shaw et 1984; McKinney et al, 1987; Shu et al, 1988; Golding et al, 1990 Golding et al, , 1992 Kaye et al, 1991; Zack 1991; Zack et al, 1991; Roman et al, 1994; Cnattingius et al, 1995) . Likewise, although it has been hypothesized that mothers of leukaemic children are more likely to have had prior fetal deaths and have fertility problems (van Steensel-Moll et al, 1985) , the evidence is sparse and contradictory (MacMahon and Newill, 1962; Shu et al, 1988; Kaye et al, 1991; Cnattingius et al, 1995) We found no evidence of any link between leukaemia and birth order, but our findings with respect to maternal age, numbers of previous pregnancies and fertility treatment highlight the complexity of the issues -the mothers of leukaemic cases being marginally older, having slightly fewer past pregnancies and being more likely to have had fertility treatment than their corresponding British Journal of Cancer (1997) 76(3), 406-415 controls. None of the differences were statistically significant, but in view of current trends with respect to fertility treatment this area may warrant further research.
CONCLUSION
The findings presented here contribute to the accumulating body of knowledge about possible prenatal origins of haematological cancers. The methods and procedures used proved to be reliable, and the investigation has now been extended to include other malignancies and other hospitals.
While some hypotheses were supported by our analyses (e.g. in utero viral exposure), others were not (e.g. neonatal vitamin K). In addition, novel associations that require confirmation in future research have emerged (e.g. maternal anaemia in pregnancy). Information on larger numbers of cases incorporating more refined diagnostic and biological information are clearly required. For children diagnosed before the age of 15 years, this should be provided by the United Kingdom Childhood Cancer Study (UKCCS), which is a collaborative study of several thousand children diagnosed with cancer in the UK. Our findings suggest, however, that prenatal factors may be important determinants of haematological malignancies in young adults, as well as in children. Given that the clearest example to date of an in utero exposure causing cancer is that of maternal diethylstilboestrol use in pregnancy and clear cell adenocarcinoma in young women (Herbst et al, 1971) , and considering the suggestions that testis cancer (Swerdlow et al, 1987) and breast cancer (Ekbom et al, 1992; Michels et al, 1996) may have a prenatal component to their aetiology, this is perhaps not unexpected.
